Literature DB >> 12804633

The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.

Clive S Zent1, Fenghuang Zhan, Steven A Schichman, Klaus H W Bumm, Pei Lin, James B Chen, John D Shaughnessy.   

Abstract

We compared gene expression in purified tumor cells from untreated patients with chronic lymphocytic (CLL) (n=24) and newly diagnosed multiple myeloma (MM) (n=29) using the Affymetrix HuGeneFL microarray with probes for approximately 6800 genes. Hierarchical clustering analysis showed that CLL and MM have distinct expression profiles (class prediction). Gene and protein expression (measured by flow cytometry) correlated well for CD19, CD20, CD23, and CD138 in CLL and MM, but not for immunoglobulin light chain, CD38 and CD79b in CLL, or CD45 and CD52 in MM. CLL and MM differentially expressed 18% of 130 apoptosis related genes, suggesting differences in mechanisms of cell survival.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12804633     DOI: 10.1016/s0145-2126(03)00015-8

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

2.  Expression of transient receptor potential vanilloid channels TRPV5 and TRPV6 in human blood lymphocytes and Jurkat leukemia T cells.

Authors:  Irina O Vassilieva; Victor N Tomilin; Irina I Marakhova; Alla N Shatrova; Yuri A Negulyaev; Svetlana B Semenova
Journal:  J Membr Biol       Date:  2012-11-01       Impact factor: 1.843

3.  Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study.

Authors:  Jane E Freedman; Martin G Larson; Kahraman Tanriverdi; Christopher J O'Donnell; Kristine Morin; Amanda S Hakanson; Ramachandran S Vasan; Andrew D Johnson; Mark D Iafrati; Emelia J Benjamin
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

Review 4.  The role of the blood transcriptome in innate inflammation and stroke.

Authors:  Jane E Freedman; Olga Vitseva; Kahraman Tanriverdi
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 5.  Advances in the understanding of biology and prognosis in chronic lymphocytic leukemia.

Authors:  Clive S Zent; Neil E Kay
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

6.  A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia.

Authors:  Daphne R Friedman; J Brice Weinberg; William T Barry; Barbara K Goodman; Alicia D Volkheimer; Karen M Bond; Youwei Chen; Ning Jiang; Joseph O Moore; Jon P Gockerman; Louis F Diehl; Carlos M Decastro; Anil Potti; Joseph R Nevins
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

7.  Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.

Authors:  Robert S Boyd; Rebekah Jukes-Jones; Renata Walewska; David Brown; Martin J S Dyer; Kelvin Cain
Journal:  Mol Cell Proteomics       Date:  2009-04-02       Impact factor: 5.911

8.  TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

Authors:  Moshe E Gatt; Kohichi Takada; Mala Mani; Mikael Lerner; Marjorie Pick; Teru Hideshima; Daniel E Carrasco; Alexei Protopopov; Elena Ivanova; Olle Sangfelt; Dan Grandér; Bart Barlogie; John D Shaughnessy; Kenneth C Anderson; Daniel R Carrasco
Journal:  Br J Haematol       Date:  2013-05-07       Impact factor: 6.998

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.